NCT05527652View on ClinicalTrials.gov

Self-Supporting Nasopharyngeal Airway (ssNPA) Treating Upper Airway Obstruction in Hypotonia

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 16, 2022

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions
Obstructive Sleep ApneaHypertonia, MuscleNasal Airway ObstructionToleranceTrisomy 21Down Syndrome
Interventions
DEVICE

Self-Supporting Nasopharyngeal Airway (ssNPA)

The ssNPA device is made of a single piece of flexible, medical-grade silicone. It is inserted through one nostril and extends to the anatomic position bypassing the upper airway obstruction above the epiglottis.

Trial Locations (1)

48109

RECRUITING

The University of Michigan, Ann Arbor

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Michigan

OTHER